Dextenza may relieve ocular itching in patients with allergic conjunctivitis for up to 4 weeks, according to a study published in American Journal of Ophthalmology.
“Because of the wide variability in allergens and in individuals’ responses to these allergens, environmental studies can introduce bias in the evaluation of potential ocular therapies,” the study authors wrote. “The standard Ora-CAC (conjunctival allergen challenge) model, on the other hand, reproducibly induces an acute moderate to severe ocular allergic reaction so that potential therapies can be studied